Commonwealth Equity Services LLC Has $45.59 Million Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Commonwealth Equity Services LLC raised its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 2.0% during the fourth quarter, Holdings Channel reports. The firm owned 76,704 shares of the biotechnology company’s stock after buying an additional 1,503 shares during the period. Commonwealth Equity Services LLC’s holdings in Axon Enterprise were worth $45,587,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in AXON. Groupama Asset Managment acquired a new stake in Axon Enterprise during the third quarter valued at approximately $200,000. Massachusetts Financial Services Co. MA bought a new position in shares of Axon Enterprise in the third quarter valued at approximately $120,553,000. Proficio Capital Partners LLC bought a new position in shares of Axon Enterprise in the fourth quarter valued at approximately $78,414,000. Westfield Capital Management Co. LP raised its stake in shares of Axon Enterprise by 12.2% in the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after acquiring an additional 127,769 shares during the last quarter. Finally, Assenagon Asset Management S.A. raised its stake in shares of Axon Enterprise by 328.7% in the fourth quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock valued at $86,354,000 after acquiring an additional 111,405 shares during the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 1,370 shares of the company’s stock in a transaction that occurred on Tuesday, December 17th. The shares were sold at an average price of $639.14, for a total value of $875,621.80. Following the completion of the sale, the insider now owns 125,950 shares of the company’s stock, valued at approximately $80,499,683. This represents a 1.08 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Michael Garnreiter sold 1,000 shares of the company’s stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $639.69, for a total transaction of $639,690.00. Following the completion of the sale, the director now directly owns 24,259 shares of the company’s stock, valued at $15,518,239.71. The trade was a 3.96 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 5,146 shares of company stock valued at $3,262,847 over the last ninety days. Insiders own 6.10% of the company’s stock.

Axon Enterprise Trading Up 4.1 %

AXON opened at $556.26 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company has a market cap of $42.62 billion, a price-to-earnings ratio of 143.74, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The firm has a 50 day simple moving average of $594.32 and a 200 day simple moving average of $532.91. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $715.99.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on AXON shares. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their target price for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Robert W. Baird lifted their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Barclays reiterated a “hold” rating on shares of Axon Enterprise in a research note on Monday. Craig Hallum cut shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday. Finally, TD Cowen initiated coverage on Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $604.67.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.